Dergiler / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 3

Treatment Results for Pineal Region Tumors: Role of Stereotactic Biopsy Plus Adjuvant Therapy vs. Open Resection

Sayfa
336–340
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: The results of the study suggests that although gross total resection is the standard of care in most pineal tumors nowadays, stereotactic biopsy followed by adjuvant therapy may still be a safe and viable option

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: Pineal tumors represent uncommon intracranial tumors with highly diverse histologic subtypes.
📊
Temel Bulgular & Veri:MATERIAL and METHODS: We present the results of 48 patients with pineal tumor treated either by stereotactic biopsy followed by adjuvant therapy (23 patients) or open surgical resection without (18 patients) or with (7 patients) adjuvant therapy in Shohada Tajrish Hospital, Iran .
💡
Sonuç & Katkı:CONCLUSION: The results of the study suggests that although gross total resection is the standard of care in most pineal tumors nowadays, stereotactic biopsy followed by adjuvant therapy may still be a safe and viable option
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

AIM: Pineal tumors represent uncommon intracranial tumors with highly diverse histologic subtypes. There still exists a controversy in literature about what influences overall survival and outcome. MATERIAL and METHODS: We present the results of 48 patients with pineal tumor treated either by stereotactic biopsy followed by adjuvant therapy (23 patients) or open surgical resection without (18 patients) or with (7 patients) adjuvant therapy in Shohada Tajrish Hospital, Iran . RESULTS: unremarkable pathology yield was 3/23 in the biopsy and 1/25 in the surgical group. Perioperative mortality and morbidity were 4.3% and 0% in the biopsy group and 32.0% and 4.0% in the surgical group. Analysis showed that age, gender, cranial nerve deficit, motor deficit, preoperative Karnofsky Performance Score (KPS), midbrain involvement, and brain stem involvement had no effect on neither perioperative mortality nor long-term survival, while local invasion and pineocytoma pathology increased perioperative mortality and presence of hydrocephalus and pineoblastoma pathology significantly decreased long-term survival. Hospitalization length was shorter in the stereotactic biopsy plus adjuvant therapy group. CONCLUSION: The results of the study suggests that although gross total resection is the standard of care in most pineal tumors nowadays, stereotactic biopsy followed by adjuvant therapy may still be a safe and viable option

🔖

Bu Makaleye Atıf Yap

MOTIEIE-LANGROUDI, R., SADEGHIAN, H., SOLEIMANI, M. M., SEDDIGHI, A. S., SHAHZADI, S. (2016). Treatment Results for Pineal Region Tumors: Role of Stereotactic Biopsy Plus Adjuvant Therapy vs. Open Resection. Turkish Neurosurgery, Cilt: 26 - Sayı: 3, 336–340. https://ajindex.com/articles/404661

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Arendt J, Skene DJ: Melatonin as a chronobiotic. Sleep Med Rev 9(1):25–39, 2005 2. Bayati A, Ghabaei M, Sadeghian H, Kolahi AS: A case control study on genetic susceptibility in Multiple Sclerosis. Iranian Journal of Neurology 7:143-152, 2008 3. Bruce JN, Ogden AT: Surgical strategies for treating patients with pineal region tumors. J Neurooncol 69(1-3):221-236, 2004 4. Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U: Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: Results of the German Cooperative Trial MAKEI 89. Klin Padiatr 216(3):141-149, 2004 5. Chao CK, Lee ST, Lin FJ, Tang SG, Leung WM: A multivariate analysis of prognostic factors in management of pineal tumor. J Radiat Oncol Biol Phys 27(5):1185-1191, 1993 6. Clark AJ, Ivan ME, Sughrue ME, Yang I, Aranda D, Han SJ, Kane AJ, Parsa AT: Tumor control after surgery and radiotherapy f or pineocytoma. J Neurosurg 113(2):319-324, 2010 7. Clark AJ, Sughrue ME, Aranda D, Parsa AT: Contemporary management of pineocytoma. Neurosurg Clin N Am 22(3):403- 407, 2011 8. Clark AJ, Sughrue ME, Ivan ME, Aranda D, Rutkowski MJ, Kane AJ, Chang S, Parsa AT: Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol 100(2):255-260, 2010 9. Fauchon F, Hasselblatt M, Jouvet A, Champier J, Popovic M, Kirollos R, Santarius T, Amemiya S, Kumabe T, Frappaz D, Lonjon M, Fèvre Montange M, Vasiljevic A: Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: A multicenter study. J Neurooncol 112(2):223- 231, 2013 10. Fauchon F, Jouvet A, Paquis P, Saint-Pierre G, Mottolese C, Ben Hassel M, Chauveinc L, Sichez JP, Philippon J, Schlienger M, Bouffet E: Parenchymal pineal tumors: A clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys 46(4):959-968, 2000 11. Fukui M, Natori Y, Matsushima T, Nishio S, Ikezaki K: Operative approaches to the pineal region tumors. Childs Nerv Syst 14(1-2):49-52, 1998 12. Ghabaee M, Bayati A, Amri Saroukolaei S, Sahraian MA, Sanaati MH, Karimi P, Houshmand M, Sadeghian H, Hashemi Chelavi L: Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cellular and Molecular Neurobiology 29:109-114, 2009 13. Ghabaee M, Omranisikaroudi M, Amrisaroukolaei S, Meysamie A, Sahraian MA, Bayati A, Sanati MH, Houshman M, Sadeghian H, Vajihazaman K: Mitochondrial mutation